跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Calan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Calan
Approved
STANDARD
Calan
The Searle Company Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
926a21019a504ce1
Company
The Searle Company Limited
Type
Standard
Approval Details
Approval Id
926a21019a504ce1
Drug Approval Philippines Name
Calan
Product Name
Calan
Registration Number
DRP-4007
Brand Name
Calan
Generic Name
Verapamil Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
80 mg
Manufacturer
The Searle Company Limited
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/the-searle-company-limited
Issuance Date
04 April 2022
Expiry Date
05 October 2027
Pharmacologic Category
Selective Calcium Channel Blocker with Direct Cardiac Effects (Phenylalkylamine Derivative)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
926a21019a504ce1
Type
Standard
Back to Philippines FDA Approvals